Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies
To review the available evidence from prospective studies on the safety and tolerability of the ketogenic diet (KD) for the treatment of refractory childhood epilepsy.
A comprehensive bibliographic search was performed with the aim of retrieving prospective studies that monitored adverse effects (AEs) in children after receiving the classic or medium-chain triglyceride KD therapy for refractory epilepsy.
A total of 45 studies were retrieved, including 7 randomized controlled trials. More than 40 categories of AEs were reported. The most common AEs included gastrointestinal disturbances (40.6%), hyperlipidemia (12.8%), hyperuricemia (4.4%), lethargy (4.1%), infectious diseases (3.8%) and hypoproteinemia (3.8%). Severe AEs, such as respiratory failure and pancreatitis, occurred in no more than 0.5% of children. Specifically, patients receiving KD therapy should be monitored for osteopenia, urological stones, right ventricular diastolic dysfunction, and growth disturbance. The total retention rates of the diet for 1 year and 2 years were 45.7% and 29.2%, respectively. Nearly half of the patients discontinued the diet because of lack of efficacy. AEs were not the main reason for the KD discontinuation. None of the 24 deaths reported after initiation of the diet was attributed to the KD.
KD is a relatively safe dietary therapy. However, because the KD can cause various AEs, it should be implemented under careful medical supervision. Continuous follow-up is needed to address the long-term impact of the diet on the overall health of children.
Keywordsadverse effects ketogenic diet prospective studies refractory childhood epilepsy tolerability
Unable to display preview. Download preview PDF.
- 5.Ketogenic Diet Study Group of the Subspecialty Group of Neurology, the Society of Pediatrics, Chinese Medical Association. Prospective multicenter study on long-term ketogenic diet therapy for intractable childhood epilepsy. Zhonghua Er Ke Za Zhi 2013;51:276–282. [In Chinese]Google Scholar
- 18.Hu Y, Lu XG, Wen JL, Wang C, Chen L, Chen Y, et al. Randomized control study on two different protocols of ketogenic diet for refractory epilepsy in children. Chin Pediatr Emerg Med 2012;19:473–476. [In Chinese]Google Scholar
- 40.Tagliabue A, Bertoli S, Trentani C, Borrelli P, Veggiotti P. Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: a 6-month prospective observational study. Clin Nutr 2012;31:246–249.CrossRefPubMedGoogle Scholar
- 42.Deng YH, Zhou JH, Li BM, Liu XR, Liao WP. Long-term retention rate and side effects of ketogenic diet in Chinese patients with refraetory epilepsy. Parenter Enter Nutr 2012;19:355–358. [In Chinese]Google Scholar
- 44.Lu ZY, Yu LF, Gong XY, Wang XH, Hua HM, Zhang LM, et al. Compliance and safety of ketogenic diet therapy for children with intractable epilepsy. Chin J Pract Pediatr 2013;28:378–381. [In Chinese]Google Scholar
- 51.Zhu DN, Xie MM, Wang J, Wang JH, Wang MM, Zhang GY, et al. Clinical observation of ketogenic diet adding for refractory epilepsy in 36 cases of children. Chin J Appl Clin Pediatr 2014;29:1483–1487. [In Chinese]Google Scholar